SCHEMBL16637918

SCHEMBL16637918

Cc1c(OC(=O)O)sc2c1c(=O)n(CCc1ccccc1)c(=O)n2CCC=C(F)F

nearest known ligand 0.56

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 16/20 0.56
ACACB O00763 1/20 0.55
ACACA Q13085 1/20 0.55
MAPT P10636 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16637583 0.90 ADORA2B (0.49) ADORA2BACACBACACA
SCHEMBL16637347 0.89 ADORA2B (0.49) ADORA2BACACBACACAMAPT
SCHEMBL16637555 0.89 ADORA2B (0.46) ADORA2BACACBACACA
SCHEMBL16637917 0.87 ADORA2B (0.71) ADORA2BACACBACACA
SCHEMBL16637408 0.85 ADORA2B (0.47) ADORA2BACACBACACA
SCHEMBL19611062 0.84 ADORA2B (0.64) ADORA2BACACBACACA
SCHEMBL19611069 0.84 ADORA2B (0.78) ADORA2B
SCHEMBL16643767 0.84 ACACB (0.61) ADORA2BACACBACACA
SCHEMBL19611089 0.83 ADORA2B (0.62) ADORA2BACACBACACA
SCHEMBL16643868 0.79 ADORA2B (0.63) ADORA2BACACBACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3055313-B1 CYCLIC THIENOURACIL CARBOXAMIDE AND ITS USE Bayer Pharma AG (DE) 2017-11-22 EP disclosed
EP-3055313-A1 CYCLIC THIENOURACIL-CARBOXAMIDES AND USE THEREOF Bayer Pharma Aktiengesellschaft (DE) 2016-08-17 EP disclosed
WO-2015052065-A1 CYCLIC THIENOURACIL-CARBOXAMIDES AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2015-04-16 WO disclosed